Biologic therapy for psoriasis reduces incident psoriatic arthritis risk by 46% compared to non-biologic therapy
Biologic Therapy Linked to Lower Risk of Psoriatic Arthritis
This meta-analysis of 124,138 patients found that biologic therapy is associated with a 46% lower risk of developing psoriatic arthritis com…
Biologic therapies, especially IL-23 and IL-17 inhibitors, are linked to a lower risk of developing psoriatic arthritis in adults with psori…
Distinct immune mechanisms and myeloid-cell activation differentiate systemic juvenile idiopathic arthritis from adult rheumatoid arthritis
New Research Highlights Differences Between Juvenile and Adult Arthritis
This narrative review synthesizes the distinct immune mechanisms and biomarker profiles of juvenile idiopathic arthritis (JIA) and adult rhe…
New research highlights how juvenile idiopathic arthritis differs from adult rheumatoid arthritis, helping doctors better tailor treatments …
Tumor necrosis factor inhibition is associated with improvements in CNS-related outcomes in rheumatoid arthritis
Tumor necrosis factor inhibitors may help brain symptoms in rheumatoid arthritis
This narrative review explores the joint-brain framework in rheumatoid arthritis, synthesizing preclinical and clinical evidence regarding n…
New research suggests that treating inflammation in rheumatoid arthritis may help with brain-related issues like fatigue, pain, and mood cha…
Cardiovascular risk for Janus kinase inhibitors in rheumatoid arthritis remains inconsistent across specific molecules
New data reveals specific risks for some rheumatoid arthritis drugs
This narrative review examines the cardiovascular safety of Janus kinase inhibitors (JAKis) in patients with rheumatoid arthritis and other …
New data shows that one specific rheumatoid arthritis drug carries a higher risk of heart problems for some patients.
Biologic and targeted synthetic DMARDs show reassuring malignancy safety in inflammatory arthritides, but non-melanoma skin cancer risk rises with TNF inhibitors
Biologics for arthritis: Cancer risk appears low overall
This narrative review of biologic and targeted synthetic DMARDs in immune-mediated inflammatory arthritides finds most therapies have reassu…
Most biologic arthritis drugs don't raise overall cancer risk, but skin cancer risk may be higher with some.
Systematic review and meta-analysis of herpes zoster risk in rheumatoid arthritis patients
Rheumatoid Arthritis Patients Face Higher Shingles Risk Than General Public
This systematic review and meta-analysis synthesized data on herpes zoster risk in rheumatoid arthritis patients. The pooled proportion of h…
People with rheumatoid arthritis have a much higher chance of getting shingles, and doctors must watch for specific risk factors like high s…